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Abstract
Introduction: The effects of obesity on pulmonary functions have not been addressed previously among Saudi
population. We aim to study the effects of obesity on spirometry tests among healthy non-smoking adults.
Methods: A cross sectional study conducted among volunteers healthy non-smoking adults Subjects. We divided
the subjects into two groups according to their BMI. The first group consisted of non-obese subjects with BMI of
18 to 24.9 kg/m2 and the second group consisted of obese subjects with BMI of 30 kg/m2 and above. Subjects
underwent spirometry tests according to American thoracic society standards with measurement of the following
values: the forced vital capacity (FVC), forced expiratory volume in one second (FEV1), peak expiratory flow rate
(PEF) and forced mid-expiratory flow (FEF25-75).
Results: The total subjects were 294 with a mean age of 32 years. There were 178 males and 116 females subjects.
We found no significant differences in FEV1 (p value = 0.686), FVC (p value = 0.733), FEV1/FVC Ratio (p value =
0.197) and FEF25-75 (p value = 0.693) between the obese and non-obese subjects. However, there was significantly
difference in PEF between the two groups (p value < 0.020).
Conclusion: Obesity does not have effect on the spirometry tests (except PEF) among health non-smoking adults.
We recommend searching for alternative diagnosis in case of findings abnormal spirometry tests results among
obese subjects.
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Introduction
Obesity is a chronic medical condition characterized by
an excessive accumulation of fat on human body that
causes a generalized increase in body mass. It is mea-
sured by using body mass index (BMI) which is a reflec-
tion of weight and height. Body mass index (BMI) is
calculated as the weight in kilograms divided by the
square of the height in meters (BMI = weight (kg)/
height (m2)). The world Health Organization (WHO)
classified obesity using BMI cut-off values of 25 and 30
kg/m2. Body mass index (BMI) of 18 to 24.9 kg/m2 is
considered normal weight, a BMI of 25.0-29.9 kg/m2 is
considered overweight and a BMI of 30 kg/m2 or higher
is considered obesity [1].
Obesity has been associated with many health conse-
quences, including but not limited to diabetes,
hypertension, hyperlpidemia, ischemic heart diseases,
obstructive sleep apnea, stroke, premature death, osteo-
porosis and a reduction of the overall quality of life [2].
Obesity affects the respiratory system as well. To inves-
tigate the effect of obesity on the respiratory system,
most researchers use values of pulmonary function tests
(PFT). The factors that usually affect the values of pul-
monary function tests are age, gender, height, race or
ethnic origin and possibly obesity. As the individual gets
older age, the lung volumes and capacities become smal-
ler and the lung volumes and capacities are larger in
males than females [3]. A short man will have generally
a smaller PFT results than a taller man of the same age.
Whites tend to have slightly larger trunks and shorter
legs compared to Blacks at a given height which corre-
sponds to vital capacities that are 10-15% larger for a
given standing height [4,5] Blacks, Hispanics and Native
Americans have different PFT results compared to Cau-
casians. Ethnic differences in PFT have also been
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Latin Americans [7] Indians [8] and South Africans [9].
Weight may have effects on pulmonary function tests
including impairment on pulmonary function testing,
small airway dysfunction and expiratory flow limitation,
alterations in respiratory mechanics, decreased chest
wall and lung compliance, decreased respiratory muscle
strength and endurance, decreased pulmonary gas
exchange, lower control of breathing, and limitations in
exercise capacity [10-13].
The interaction between obesity and PFT has not been
addressed previously among the Saudi Arabian popula-
tion. Therefore, we aim to study the effects of obesity
on spirometry tests among healthy non-smoking adults
in Saudi Arabia. Our study is limited to spirometry part
of PFT because spirometry tests are considered to be
the initial screening tool for pulmonary diseases, they
are the most widely used tests, and they are easy to con-
duct using equipment that is available in all pulmonary
functions laboratories.
Methods
This is a cross sectional study conducted at the pulmon-
ary function laboratory of king Abdulaziz medical city,
Riyadh, Saudi Arabia. The subjects were selected from
the adult male and female population (aged 18 to 75
years) of healthy volunteers or hospital visitors or rela-
tives of patients visiting the hospital. The subjects who
accepted the invitation underwent a medical evaluation
including a meticulous and thorough medical history,
and a full physical examination. Subjects were Saudis
lifetime nonsmoker for either cigarettes or water pipes
(Shisha) with a weight ranges from 40 kg to 120 kg and
height range from 140 cm to 190 cm. They had no his-
tory of any respiratory complaints like cough, shortness
of breath, wheezes or fever or history of upper respira-
tory tract infection in the past 4 weeks or history of
respiratory diseases such as pulmonary tuberculosis or
asthma and not having history of cardiac or thoracic
surgery or features suggestive of cardiac or lung disease
or evidence of chest deformities or serious medical con-
ditions, and not having worked in environments with a
high concentration of dust or pollution.
T h es e x ,a g e ,s t a n d i n gh e i g h ta n db o d yw e i g h to fa l l
subject met the inclusion were recorded. The weight
was measured with the subjects wearing light clothing
and barefoot on a SECA weighting scale (Hamburg,
Germany). The standing height was measured without
shoes with the subject’s back to a vertical backboard.
Both the heels were placed together, touching the base
of the vertical board. Normal weight and obesity were
defined on the basis of WHO cutoffs. The spirometry
tests were conducted using a Micro-Loop Viasys Health-
care (Ireland). The spirometry device was calibrated
with JAEGER calibration pump using 3.0 L syringe at
three flow rates, in accordance with the manufacturer’s
recommendations, before each day’s testing and after
every few hours of testing. All Subjects underwent spiro-
metry tests, using techniques recommended by the
American Thoracic Society (ATS). The spirometry test
was done in the morning by at least two trained quali-
fied technicians. The subjects underwent the spirometry
test in the sitting position, wearing a nose clip. Unifor-
mity of spirometry test was assured by using the same
device brand for all the subjects. The validity of the test
was verified according to the ATS recommendations.
The spirometry tests measured were the forced vital
capacity (FVC), forced expiratory volume in one second
(FEV1), peak expiratory flow rate (PEFR) and forced
mid-expiratory flow (FEF25-75%). In addition to these
measured parameters, the ratio of FEV1 to FVC (FEV1/
FVC, expressed as a percentage) was calculated. The
subjects were divided into two groups according to their
BMI. The first group consisted of non-obese (normal
body weight) subjects with BMI of 18 to 24.9 kg/m2
and the second group consisted of obese subjects with
BMI of 30 kg/m2 and above
The statistical analysis was performed using the SPSS
18 software (SPSS, Chicago). Descriptive statistics were
calculated for the total study sample, for males and
females and for both groups using means and standard
deviations. The variables were expressed as the means
and standard deviations, and p value less than 5% was
considered statistically significant. Independent samples
test was used to compare the spirometry results of
obese to non-obese subjects. The Institutional Review
Board at King Abdullah International Medical Research
Centre (KAIMRC) approved the study and written
informed consent was obtained from all subjects.
Results
The baseline characteristics of study subjects are shown
in Table 1. The total study population was 294 subjects
with a mean age of 32 years. There were 178 males sub-
jects (60.5%) and 116 females subjects (39.5%). We
found no significant difference in age (p value = 0.974)
or BMI (P value = 0.755) between the males and females
subjects. With regard to spirometry tests, we found sig-
nificant differences in the FEV1 (p value < 0.001), FVC
(p value < 0.001), PEF (p value < 0.001) and FEF 25-75
(p value < 0.004), between the male and female subjects
(Table 1). We grouped the data from males and females
together because there was no significant difference
between males and females for the effects of BMI on
the spirometric values (p value = 0.423).
In comparing the spirometric values between non-
obese and obese subjects, we found no significant differ-
ences in FEV1 (p value = 0.686), FVC (p value = 0.733),
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value = 0.693) between the two groups. However, there
was significantly difference in PEF between the two
groups (p value < 0.020). The obese subjects had lower
PEF values than those non-obese subjects (Table 2).
Discussion
The main results of our study showed that there were
no significant differences between the obese and non-
obese subjects in FEV1, FVC, FEV1/FVC ratio and FEF
25-75; however, there was a significant difference
between the two groups in regard to PEF. The obese
subjects had lower PEF values than the non-obese
subjects. Low PEF in obese subjects can be explained by
an increase in total respiratory resistance and airway
resistance with obesity. The higher airway resistance, the
higher BMI and subsequently, the lower PEF [14].
To our knowledge, this is the first study to address the
relationship between obesity and spirometry tests among
the Middle East population. Many studies conducted in
the rest of the world and addressed such relationship
showed heterogeneous results. The effects of obesity on
spirometric values are not consistent across all studies
with some studies shown no effects and some other stu-
dies shown positive effects. This discrepancy between
studies could be explained by the wide variations in eth-
nicity of different population in PFT values or this may
be a result of methodological differences in these
studies.
However all studies that addressed other pulmonary
function tests values (e.g. lung volumes and capacities)
showed that the obesity directly correlated with these
values. Our study was limited to the spirometric values
(FEV1, FVC, FEV1/FVC, FEF 25-75 and PEF) and did
not include the other pulmonary function tests (e.g.
lung volumes and capacities).
In contrast to other studies, a study conducted by
Costa D et al. addressed the relationship between spiro-
metric tests and obesity produced results similar to
those of our study. The author recruited 20 obese young
women with a BMI of 35-49.99 kg/m2 who were seden-
tary, non-smokers and had no lung disease and 20 non-
obese control young women who were also sedentary
non-smokers and had no lung diseases with body mass
indices between 18.5 and 24.99 kg/m2. There were no
significant differences between the obese group and the
non-obese group with respect to the age, vital capacity
( V C ) ,t i d a lv o l u m e( T V ) ,F V C ,a n dF E V 1 .H o w e v e r ,t h e
Table 1 The baseline characteristics and spirometry tests
variables of the study subjects
Male (n =
178)
Females (n =
116)
Total (n =
294)
Mean Std.
Dev
Mean Std.
Dev
P
value
Mean Std.
Dev
Age (years) 32.19 10.164 32.15 9.639 .974 32.17 9.943
Height (cm) 171.87 6.261 159.16 5.975 < .001 166.85 8.739
Weight (kg) 84.21 18.212 71.50 18.325 < .001 79.19 19.258
BMI (kg/m
2) 28.503 5.9454 28.253 7.1559 .755 28.404 6.4395
FEV1 (L) 3.6363 .44796 2.6692 .37764 < .001 3.2548 .63356
FEV1% 92.51 9.938 93.48 9.554 .406 92.89 9.784
FVC (L) 4.4958 .56783 3.2129 .47231 < .001 3.9897 .82270
FVC % 95.83 10.109 97.99 10.522 .078 96.68 10.311
PEF(L/min) 560.47 76.552 393.54 51.952 < .001 494.61 106.201
PEF % 100.76 13.228 98.80 12.942 .211 99.99 13.129
FEV1/FVC
Ratio
80.98 3.646 82.72 2.954 < .001 81.67 3.489
FEF 25-75
(L)
3.4693 .71140 2.6894 .48920 < .001 3.1616 .73854
FEF 25-75% 75.59 15.894 70.95 11.262 .004 73.76 14.406
Table 2 Independent sample test comparing age, BMI and spirometric variables between non-obese and obese
subjects
Group 1 (non-obese) Group 2 (obese)
Mean SD Mean SD Mean difference 95% CI P value
Height (cm) 166.75 8.55 166.95 8.93 -0.19 (-2.20, 1.81) 0.848
Weight (kg) 62.40 8.36 94.67 12.16 -32.26 (-34.67, -29.84) < .00001
BMI (kg/m
2) 22.37 1.82 33.95 3.47 -11.58 (-12.22, 10.93) < .00001
FEV1 (L) 3.27 0.56 3.24 0.69 0.02 (-0.11, 0.17) 0.686
FEV1% 91.95 9.41 93.76 10.06 -1.81 (-4.05, 0.42) 0.110
FVC (L) 4.00 0.75 3.97 0.88 0.03 (-0.15, 0.22) 0.733
FVC % 95.83 10.10 97.46 10.47 -1.63 (-4.00, 0.73) 0.175
PEF(L/min) 508.42 113.65 479.62 95.62 -28.80 (-53.02, -4.59) 0.020
PEF % 103.09 13.13 96.62 12.30 -6.46 (-9.39, -3.53) < .00001
FEV1/FVC Ratio 81.94 3.86 81.41 3.09 0.53 (-0.26, 1.33) 0.197
FEF 25-75 (L) 3.14 0.63 3.17 0.82 -0.03 (-0.20, 0.13) 0.693
FEF 25-75% 72.12 13.01 75.27 15.47 -3.14 (-6.44, 0.14) 0.061
Al Ghobain BMC Pulmonary Medicine 2012, 12:10
http://www.biomedcentral.com/1471-2466/12/10
Page 3 of 5obese group had a greater inspiratory reserve volume
(IRV), a lower expiratory reserve volume (ERV), and
lower maximal voluntary ventilation (MVV) than the
non-obese group [15].
Jones RL et al. studied pulmonary function test results
from 373 patients with wide range of BMIs. He found
significant inverse relationships between BMI and the
values of VC and total lung capacity (TLC). Moreover,
the functional residual capacities (FRC) and ERV
decreased exponentially with increasing BMI, to the
extent that morbid obesity resulted in the patients
breathing near their residual volumes (RV) [16]. Accord-
ing to Koenig, this fact is attributable to pressing the
diaphragm upwards due to the expanded abdominal
volume of obese individuals [11].
In mild obesity, the spirometry results may be normal
or may suggest a restrictive process, with a symmetric
r e d u c t i o ni nF E V 1a n dF V C[ 1 7 ]o no t h e rh a n d ,T h e
VC and TLC are well preserved in mild obesity because
there is a compensatory increase in inspiratory capacity
(IC). It is therefore important to be able to separate the
changes that may be explained by an increased BMI
from those that may be related to another process. At
present, there is no way to differentiate these factors
other than a conducting a careful history and physical
examination combined with other clinical data [18].
The most important change in pulmonary functions in
obesity is a decrease in lung compliance due to the
increased the weight of chest wall and the higher posi-
tion of diaphragm in the thoracic cavity resulting in a
decrease in the lung functions which subsequently leads
to increase in work of breathing [16]. In addition, the
deposition of fat on the chest wall may impede the
expansion and excursion of the rib cage, through a
direct loading effect or by altering the inter-costal mus-
cle function [19]. Furthermore, obesity has been shown
to be associated with markers of systemic and vascular
inflammation such as the hormone leptin [20]. These
inflammatory factors may exert local effects on lung tis-
sue, leading to subtle reductions in airway diameter.
The Strength of our study is the recruitment of sub-
jects who were healthy without co-morbidity and the
selection of subjects for the study who had been seen by
a physician prior to being tested, and there were no
indications that they had any co-morbidity. Anther
strength of this study is that it is the first study in Saudi
Arabia and among Middle East population to address
the relationship between obesity and spirometry tests
values.
Our study had the limitation of using BMI as an
indictor of obesity. BMI is a global measure of body
mass that includes both fat and lean mass and takes no
account of differences in fat distribution. If the reduc-
tion of lung volumes in obesity is due to a direct
mechanical effect on lung volumes, then the distribution
of body fat should modify the relationship between BMI
and lung volumes. Abdominal and thoracic fat are likely
to have direct effects on the downward movement of
the diaphragm and on chest wall properties, while fat on
t h eh i p sa n dt h i g h sw o u l db el e s sl i k e l yt oh a v ea n y
direct mechanical effect on the lungs. However, the
standard classification of obesity uses BMI as a reflec-
tion of obesity and this classification is used globally by
WHO and other related health organizations. It is con-
sidered to be the gold standard at the present time.
Another limitation in our study is that we did not
measure all the pulmonary function tests variables; our
study was limited to the spirometry tests values and did
not include lung volumes measurements. We elected to
limit our study to the spirometry tests values because
these values had not been previously investigated in
relation to obesity in the Saudi population, and will be
very difficult to apply data from other parts of the world
to the Saudi population due to the differences in ethni-
city. Our study addressed an important gap in the litera-
ture regarding the effects of obesity on spirometry tests
values among Saudi population.
In conclusion, obesity does not have direct effect on
the spirometry tests results (except PEF) among health
non-smoking adults Saudis and if there is any effect, it
should be explained by alternative diagnosis or underly-
ing respiratory diseases. We strongly recommend con-
ducting larger study including all pulmonary functions
tests variables (spirometry tests and other lung volumes)
among Saudi population, moreover, it will interesting to
use other indices of obesity like abdominal girth, sub-
scapular skin fold thickness, and the ratio of abdominal
girth to hip breadth as reflection of obesity instead of
BMI and find if such results will differ in comparison to
the results of using BMI.
Based on our result, we highly recommend to physi-
cians who use spirometry test in their practice to search
for alternative diagnosis in case of findings abnormal
spirometry tests results among obese individuals as
these abnormal findings should not attributed to obesity
per se.
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